New hope for aggressive breast cancer: Three-Drug combo trial launches
NCT ID NCT06690840
Summary
This study is testing whether combining three drugs—atezolizumab, vinorelbine, and cyclophosphamide—can help control advanced triple-negative breast cancer in patients who have already received immunotherapy. The trial aims to see if this combination can shrink tumors and extend survival for people with this aggressive cancer type. Researchers will enroll 45 participants with metastatic disease that cannot be surgically removed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Sanitaria Locale Br
NOT_YET_RECRUITINGBrindisi, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
European Institute of Oncology
RECRUITINGMilan, 20141, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fondazione IRCCS San Gerardo Dei Tintori
RECRUITINGMonza, Monza, 20900, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NOT_YET_RECRUITINGRoma, Roma, 00168, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NOT_YET_RECRUITINGRoma, Roma, 00168, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.